Calls Now Open
2022 ADDF-Harrington and 2023 Harrington UK Rare Disease Programs
Jeffrey Clark Klein, PhD, MBA, is a Project Manager at Harrington Discovery Institute. Jeff provides project management support to Harrington Scholars and the Therapeutic Development Center to efficiently advance therapeutic assets toward clinical use.
Prior to joining Harrington Discovery Institute in October 2019, Jeff spent 10 years in positions that focused on commercial translation of early stage therapeutics, including in academic technology transfer (Case Western Reserve University and the Johns Hopkins University), government technology transfer (the National Institutes of Health), and small biotech (NovelMed Therapeutics). In his positions within academic and government technology transfer, Jeff led and supported various internal translational funding programs, including use of non-dilutive funding sourced by the federal government, state government, and a foundation, as well as an equity-based mechanism for Case Western Reserve University startups.
Jeff received his PhD from the Johns Hopkins University. His thesis focused on HIV-1 gp120 drug and vaccine design and he was a core contributor to a fully funded, multi-institutional, translationally-focused project.
Jeff received his MBA from Case Western Reserve University’s Weatherhead School of Management. Jeff is a Registered Patent Agent.